This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
by Zacks Equity Research
GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
UHSPositive Net Change AVAHPositive Net Change ATIPNegative Net Change GEHCPositive Net Change
medical medical-devices
Tempus Stock Up Following Collaboration Expansion in Oncology R&D
by Zacks Equity Research
TEM's latest expanded partnership is likely to leverage multimodal real-world datasets and biological model systems in oncology R&D.
BAXNegative Net Change DVAPositive Net Change TAKPositive Net Change TEMNegative Net Change
medical medical-devices
A Closer Look at Wide Moat Stocks
by Derek Lewis
The essence of the "wide moat" investment theme is when businesses possess durable competitive advantages - dubbed moats - that shield them from competitors.
LMTNo Net Change UNHPositive Net Change TSMPositive Net Change
aerospace medical-devices semiconductor
Baxter Shares May Gain on the Launch of Its Latest Vest APX System
by Zacks Equity Research
BAX launches its next-generation airway clearance system, The Vest APX System, for chronic lung conditions.
DGXPositive Net Change UHSPositive Net Change BAXNegative Net Change ABMNegative Net Change
medical medical-devices
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock
by Zacks Equity Research
Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.
BSXPositive Net Change MDTNegative Net Change AXGNNegative Net Change PAHCPositive Net Change
medical medical-devices
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
by Zacks Equity Research
XRAY continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
BSXPositive Net Change XRAYNegative Net Change COONegative Net Change STAAPositive Net Change
medical medical-devices
PDCO Shares Gain Following New Deals to Boost Animal Health Business
by Zacks Equity Research
Patterson Companies announces to invest in two separate businesses to boost its animal health business.
DGXPositive Net Change UHSPositive Net Change PDCONegative Net Change ABMNegative Net Change
medical medical-devices
Do Options Traders Know Something About Agios (AGIO) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Agios (AGIO) stock based on the movements in the options market lately.
AGIOPositive Net Change
medical medical-devices
HOLX Stock Gains From New Offerings Despite Macro Issues
by Zacks Equity Research
In Breast Health, Hologic expands its product offering from imaging to cover the continuum of breast cancer care, including biopsy and surgery.
HOLXNegative Net Change AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change
medical medical-devices
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device
by Zacks Equity Research
AXNX's R20 rechargeable SNM system, offering long-lasting treatment for bladder and bowel dysfunction, gains approval in Australia.
UHSPositive Net Change AXNXNegative Net Change AVAHPositive Net Change ATIPNegative Net Change
medical medical-devices
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ATATPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is HOLX Stock a Smart Hold for Your Portfolio Right Now?
by Zacks Equity Research
Hologic's strength in Molecular Diagnostics is highly promising. Yet, macroeconomic uncertainties can pose headwinds for its operations.
BSXPositive Net Change HOLXNegative Net Change AXGNNegative Net Change TMDXNegative Net Change
medical medical-devices
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now
by Zacks Equity Research
FMS continues to gain traction on the back of its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.
UHSPositive Net Change DVAPositive Net Change FMSPositive Net Change AZPNPositive Net Change
medical medical-devices
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels
by Zacks Equity Research
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays.
BSXPositive Net Change QGENPositive Net Change AXGNNegative Net Change PAHCPositive Net Change
medical medical-devices
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?
by Indrajit Bandyopadhyay
DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
DVAPositive Net Change PNTGNegative Net Change AVAHPositive Net Change
medical medical-devices
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
by Zacks Equity Research
Entera and OPKO Health announce positive PK/PD results from their ongoing collaborative research focused on developing the first oral dual agonist GLP-1/glucagon peptide.
DGXPositive Net Change UHSPositive Net Change OPKNegative Net Change ENTXPositive Net Change
medical medical-devices
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
by Zacks Equity Research
Strength in NVRO's Senza Platform and business diversification plans raises optimism about the stock.
DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change NVRONegative Net Change
medical medical-devices
MultiPlan Stock Falls Even After NRHA Rural Healthcare Deal
by Zacks Equity Research
MPLN and NRHA team up to empower rural healthcare providers with innovative technology and data-driven solutions, improving access, quality and affordability.
UHSPositive Net Change MPLNPositive Net Change AVAHPositive Net Change ATIPNegative Net Change
medical medical-devices
Tactile Medical Stock Rises After Positive Flexitouch Trial Results
by Zacks Equity Research
TCMD announces a new study evaluating Flexitouch. The study reveals significant improvements in health-related quality of life and clinical outcomes.
UHSPositive Net Change TCMDPositive Net Change AVAHPositive Net Change ATIPNegative Net Change
medical medical-devices
Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock
by Zacks Equity Research
Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.
AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change HYPRNegative Net Change
medical medical-devices
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
by Zacks Equity Research
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
BSXPositive Net Change MDTNegative Net Change AXGNNegative Net Change PAHCPositive Net Change
medical medical-devices
After Golden Cross, Intercorp Financial Services Inc. (IFS)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IFSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Retain Stryker Stock in Your Portfolio for Now
by Zacks Equity Research
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
UHSPositive Net Change SYKPositive Net Change DVAPositive Net Change AZPNPositive Net Change
medical medical-devices
NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform
by Zacks Equity Research
Nevro announces the FDA approval and limited market release of HFX iQ with HFX AdaptivAI.
DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change NVRONegative Net Change
medical medical-devices
Reasons to Retain Veeva Systems Stock in Your Portfolio Now
by Zacks Equity Research
VEEV's robust product portfolio raises optimism about the stock. However, stiff competition and escalating costs are concerning.
DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change VEEVPositive Net Change
medical medical-devices